<?xml version='1.0' encoding='utf-8'?>
<document id="21980964"><sentence text="Potential pharmacodynamic drug-drug interaction between concomitantly administered lisinopril and diclofenac sodium: a call for appropriate management in hypertensive osteoarthritic patients."><entity charOffset="83-93" id="DDI-PubMed.21980964.s1.e0" text="lisinopril" /><entity charOffset="98-115" id="DDI-PubMed.21980964.s1.e1" text="diclofenac sodium" /><pair ddi="false" e1="DDI-PubMed.21980964.s1.e0" e2="DDI-PubMed.21980964.s1.e0" /><pair ddi="false" e1="DDI-PubMed.21980964.s1.e0" e2="DDI-PubMed.21980964.s1.e1" /></sentence><sentence text="The present study was designed as an open label, multiple-dose, randomized, parallel trial to evaluate the pharmacodynamic drug-drug interaction of lisinopril and concomitantly administered diclofenac sodium in non-diabetic and diabetic, mild to moderate hypertensive, osteoarthritic patients"><entity charOffset="148-158" id="DDI-PubMed.21980964.s2.e0" text="lisinopril" /><entity charOffset="190-207" id="DDI-PubMed.21980964.s2.e1" text="diclofenac sodium" /><pair ddi="false" e1="DDI-PubMed.21980964.s2.e0" e2="DDI-PubMed.21980964.s2.e0" /><pair ddi="false" e1="DDI-PubMed.21980964.s2.e0" e2="DDI-PubMed.21980964.s2.e1" /></sentence><sentence text="" /><sentence text="Post-screening and on inclusion, patients were put on a 2-week washout period and then randomly assigned to either only lisinopril 10 mg or combination of lisinopril 10 mg and diclofenac sodium 100 mg treatments for 8-12 weeks in diseased states of hypertension and osteoarthritis with or without type 2 diabetes mellitus"><entity charOffset="120-130" id="DDI-PubMed.21980964.s4.e0" text="lisinopril" /><entity charOffset="155-165" id="DDI-PubMed.21980964.s4.e1" text="lisinopril" /><entity charOffset="176-193" id="DDI-PubMed.21980964.s4.e2" text="diclofenac sodium" /><pair ddi="false" e1="DDI-PubMed.21980964.s4.e0" e2="DDI-PubMed.21980964.s4.e0" /><pair ddi="false" e1="DDI-PubMed.21980964.s4.e0" e2="DDI-PubMed.21980964.s4.e1" /><pair ddi="false" e1="DDI-PubMed.21980964.s4.e0" e2="DDI-PubMed.21980964.s4.e2" /><pair ddi="false" e1="DDI-PubMed.21980964.s4.e1" e2="DDI-PubMed.21980964.s4.e1" /><pair ddi="false" e1="DDI-PubMed.21980964.s4.e1" e2="DDI-PubMed.21980964.s4.e2" /></sentence><sentence text="" /><sentence text="The blood pressure (BP) control with lisinopril was reduced by concomitantly administered diclofenac sodium in non-diabetic (SBP: p=0"><entity charOffset="37-47" id="DDI-PubMed.21980964.s6.e0" text="lisinopril" /><entity charOffset="90-107" id="DDI-PubMed.21980964.s6.e1" text="diclofenac sodium" /><pair ddi="false" e1="DDI-PubMed.21980964.s6.e0" e2="DDI-PubMed.21980964.s6.e0" /><pair ddi="false" e1="DDI-PubMed.21980964.s6.e0" e2="DDI-PubMed.21980964.s6.e1" /></sentence><sentence text="00002; DBP: p=0" /><sentence text="000008) and diabetic (SBP: p=0" /><sentence text="002; DBP: p=0" /><sentence text="001) patients when compared with the patients receiving lisinopril alone"><entity charOffset="56-66" id="DDI-PubMed.21980964.s10.e0" text="lisinopril" /></sentence><sentence text=" Insulin sensitivity was improved (p=0" /><sentence text="00002) and urinary albumin excretion rate was better controlled (p=0" /><sentence text="0096) in lisinopril-treated patients when compared with the combination treatment in diabetic pool" /><sentence text=" Serum creatinine levels increased significantly in non-diabetic patients (p=0"><entity charOffset="7-17" id="DDI-PubMed.21980964.s14.e0" text="creatinine" /></sentence><sentence text="00004) receiving combination treatment" /><sentence text=" In addition, creatinine clearance (CLCR) and blood urea nitrogen (BUN) were significantly higher in diabetic (CLCR: p&lt;0"><entity charOffset="14-24" id="DDI-PubMed.21980964.s16.e0" text="creatinine" /><entity charOffset="52-65" id="DDI-PubMed.21980964.s16.e1" text="urea nitrogen" /><entity charOffset="67-70" id="DDI-PubMed.21980964.s16.e2" text="BUN" /><pair ddi="false" e1="DDI-PubMed.21980964.s16.e0" e2="DDI-PubMed.21980964.s16.e0" /><pair ddi="false" e1="DDI-PubMed.21980964.s16.e0" e2="DDI-PubMed.21980964.s16.e1" /><pair ddi="false" e1="DDI-PubMed.21980964.s16.e0" e2="DDI-PubMed.21980964.s16.e2" /><pair ddi="false" e1="DDI-PubMed.21980964.s16.e1" e2="DDI-PubMed.21980964.s16.e1" /><pair ddi="false" e1="DDI-PubMed.21980964.s16.e1" e2="DDI-PubMed.21980964.s16.e2" /></sentence><sentence text="00001; BUN: p=0"><entity charOffset="7-9" id="DDI-PubMed.21980964.s17.e0" text="BUN" /></sentence><sentence text="0098) as well as in non-diabetic (CLCR: p&lt;0" /><sentence text="00001; BUN: p=0"><entity charOffset="7-9" id="DDI-PubMed.21980964.s19.e0" text="BUN" /></sentence><sentence text="03) patients treated with combination treatment" /><sentence text=" The alterations in serum electrolytes, reduction in % platelet aggregation activity and improvement in lipid profile was more profound with combination treatment in comparison to lisinopril alone"><entity charOffset="180-190" id="DDI-PubMed.21980964.s21.e0" text="lisinopril" /></sentence><sentence text="" /><sentence text="The antihypertensive efficacy and insulin sensitivity improving property of lisinopril along with the renal function might get worse in hypertensive osteoarthritic patients receiving concomitant treatment of oral diclofenac sodium with lisinopril"><entity charOffset="76-86" id="DDI-PubMed.21980964.s23.e0" text="lisinopril" /><entity charOffset="213-230" id="DDI-PubMed.21980964.s23.e1" text="diclofenac sodium" /><entity charOffset="236-246" id="DDI-PubMed.21980964.s23.e2" text="lisinopril" /><pair ddi="false" e1="DDI-PubMed.21980964.s23.e0" e2="DDI-PubMed.21980964.s23.e0" /><pair ddi="false" e1="DDI-PubMed.21980964.s23.e0" e2="DDI-PubMed.21980964.s23.e1" /><pair ddi="false" e1="DDI-PubMed.21980964.s23.e0" e2="DDI-PubMed.21980964.s23.e2" /><pair ddi="false" e1="DDI-PubMed.21980964.s23.e1" e2="DDI-PubMed.21980964.s23.e1" /><pair ddi="false" e1="DDI-PubMed.21980964.s23.e1" e2="DDI-PubMed.21980964.s23.e2" /></sentence><sentence text=" In addition to this, close monitoring of serum electrolytes is also suggested to rule out any long-term detrimental effect" /><sentence text="" /></document>